Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of injectable cetriptyline for hematological diseases
ChiCTR2500106789Phase 4Not yet recruiting
- Sponsor
- Guangdong Provincial Hosipital of Chinese Medicine
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of thiotepa in Hematopathy, sponsored by Guangdong Provincial Hosipital of Chinese Medicine. Primary endpoint: Adverse events. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
thiotepa
03
Conditions
Hematopathy
Beyond the preview
Go deeper on ChiCTR2500106789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106789.